-
Article
Open AccessUse of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
Hematopoietic stem cell transplantation (HSCT) is an established procedure for many acquired and congenital disorders of the hematopoietic system. A record number of 42 171 HSCT in 37 626 patients (16 030 allo...
-
Article
Erratum: Latin America: the next region for haematopoietic transplant progress
Correction to: Bone Marrow Transplantation (2017) 52, 671–677; doi:10.1038/bmt.2016.361; published online 23 January 2017 Since the online publication of this article, the authors realised there were errors in...
-
Article
Latin America: the next region for haematopoietic transplant progress
Haematopoietic cell transplant activity in the 28 countries comprising Latin America is poorly defined. We conducted a voluntary survey of members of the Latin American Bone Marrow Transplantation Group regard...
-
Article
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)
Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 000 transplants reported in 2014. Transplant-related mortality remains high in allogeneic HSCT (10–20%); high-...
-
Article
Open AccessHematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. T...
-
Article
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey
Data on 68 146 hematopoietic stem cell transplants (HSCTs) (53% autologous and 47% allogeneic) gathered by 1566 teams from 77 countries and reported through their regional transplant organizations were analyze...
-
Article
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities
Unrelated donor searches in Switzerland require high-resolution HLA ty** for HLA-A/B/C/DRB1/DRB3,4/DQB1 loci. We evaluated this strategy accepting donors with ⩾9/10 match. Of 802 unrelated donor transplants ...
-
Article
Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT
-
Article
Open AccessHematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogenei...
-
Article
Open AccessHematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
In all, 661 of 680 centers in 48 countries reported 37 818 hematopoietic SCT (HSCT) in 33 678 patients (14 165 allogeneic (42%), 19 513 autologous (58%)) in the 2012 survey. Main indications were leukemias, 10...
-
Article
Open AccessHematopoietic SCT in Europe: data and trends in 2011
In all, 651 from 680 centers in 48 countries reported 35 660 hematopoietic SCT (HSCT) in 32 075 patients (13 470 allogeneic (42%), 18 605 autologous (58%)) to the 2011 survey. Main indications were: leukemias;...
-
Article
The EBMT activity survey: 1990–2010
A total of 654 centers from 48 countries were contacted for the 2010 survey. In all, 634 centers reported a total of 33 362 hematopoietic SCT (HSCT) with 30 012 patients receiving their first transplant (12 27...
-
Article
The EBMT activity survey 2009: trends over the past 5 years
Six hundred and twenty-four centers from 43 countries reported a total of 31 322 hematopoietic SCT (HSCT) to this 2009 European Group for Blood and Marrow Transplantation (EBMT) survey with 28 033 first transp...
-
Article
The EBMT activity survey 2008: impact of team size, team density and new trends
Six hundred and fifteen centers from 45 countries reported a total 30 293 HSCT to this 2008 EBMT survey with 26 810 first transplants (40% allogeneic, 60% autologous). This corresponds to an increase of 7% for...
-
Article
Erratum: Allogeneic hematopoietic SCT for patients with autoimmune diseases
Correction to: Bone Marrow Transplantation (2009) 44, 27–33; doi:10.1038/bmt.2008.424 Since the publication of their paper, the authors have noticed that one of the co-authors is not listed. C Urban, who is at...
-
Article
Allogeneic hematopoietic SCT for patients with autoimmune diseases
Allogeneic hematopoietic SCT (HSCT) has been used as treatment for single patients with autoimmune diseases (AD). To summarise currently available information, we analyzed all patients who underwent allogeneic...
-
Article
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies
The 2007 report describes the current status of HSCT activity in Europe, highlights the increasing role of allogeneic HSCT in treatment of AML and gives the first quantitative information on novel cellular the...
-
Article
Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model
New concepts of allogeneic hematopoietic SCT (allo-HSCT) for neuroblastoma and other solid tumors do not rely on escalation of chemotherapy intensity and tumor load reduction but rather on a graft-vs-tumor eff...
-
Article
Why are there regional differences in stem cell transplantation activity? An EBMT analysis
Differences in the number of hematopoietic SCTs (HSCT), in transplant rates, in indications and in techniques between countries have been reported. They were attributed mainly to differences in the economic si...
-
Article
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products
This report describes the hematopoietic stem cell transplantation (HSCT) activity in Europe in 2006 by indication, donor type and stem cell source. It illustrates differences compared to previous years and con...
